Inflammatory breast cancer.
Of all malignancies in women, perhaps none is as lethal or as frustrating to the surgeon as inflammatory breast cancer. No significant progress in curing or controlling inflammatory breast cancer was made until the last decade, when investigators, noting the futility of local therapies, applied systemic therapies with some significant improvement in survival. This article outlines the epidemiology, clinical signs, differential diagnosis, pathology, and treatment of this disease.
D001943:Breast Neoplasms / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000601:surgery; D003131:Combined Modality Therapy; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D008413:Mastitis / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology / Q000601:surgery; D008875:Middle Aged; D011247:Pregnancy; D011379:Prognosis